September 21, 2014 6:17 PM ET

Capital Markets

Company Overview of Domain Associates, L.L.C.

Company Overview

Domain Associates, L.L.C. is a private equity and venture capital firm specializing in investments in incubation, seed/start up, early venture, growth capital, PIPEs, and emerging growth companies. Within life sciences, it typically invests in healthcare companies with a focus on bio/pharmaceuticals, specialty pharmaceuticals, drug and device sectors, medical devices, biomaterials, bioinstrumentation, diagnostics, tools and instrumentation, and healthcare IT (HCIT). The firm prefers to be a part of the first institutional financing round of a company and may also invest at other stages. It prefers to takes a board seat in its portfolio companies. The firm may also invest in public companies....

One Palmer Square

Suite 515

Princeton, NJ 08542

United States

Founded in 1985

Phone:

609-683-5656

Fax:

609-683-9789

Key Executives for Domain Associates, L.L.C.

Partner
Age: 74
Partner
Age: 72
Partner
Age: 67
Partner
Age: 64
Partner
Age: 56
Compensation as of Fiscal Year 2014.

Domain Associates, L.L.C. Key Developments

Domain Associates, L.L.C. Presents at Boston CEO Conference, Jun-05-2014 03:30 PM

Domain Associates, L.L.C. Presents at Boston CEO Conference, Jun-05-2014 03:30 PM. Venue: Four Seasons Hotel, 200 Boylston Street, Boston, MA 02116, Massachusetts, United States. Speakers: Brian K. Halak, Partner.

Domain Associates, L.L.C. Presents at Women's Alternative Investment Summit, Nov-08-2013 12:00 PM

Domain Associates, L.L.C. Presents at Women's Alternative Investment Summit, Nov-08-2013 12:00 PM. Venue: The Pierre - New York, 2 East 61st Street (at 5th Avenue), Midtown Manhattan, NY 10065, New York, United States. Speakers: Nicole Vitullo, Partner.

Domain Associates LLC and RUSNANO Announce Joint Venture to Build New Pharmaceutical Plant

The Government of Kaluga Region, the Administrative Board of the City of Kaluga and NovaMedica pharmaceutical company have signed an agreement on the execution of an investment project to build a new pharmaceutical plant in the region. The new plant will be built under a joint venture between Domain Associates LLC and RUSNANO. Around $85 million will be invested in NovaMedica's new plant. The size of the land plot, where NovaMedica's production facilities will be constructed, occupies a total surface area of 50,000 square meters. On-site construction is scheduled for the second half of 2013. The factory will focus on manufacturing innovative pharmaceutical products and medical devices, which will be licensed to NovaMedica under RUSNANO/Domain Associates Agreement and subject to joint financing of late-stage life sciences developments.

Similar Private Companies By Industry

Company Name Region
SP Securities LLC United States
TENCO, INC. United States
FIG Partners, LLC, Research Division United States
FIDES Capital Partners, LLC United States
RJO Futures, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
August 19, 2014
Fractyl Laboratories, Inc.
Private Placement
July 30, 2014
Epic Sciences Inc.
Merger/Acquisition
June 17, 2014
ProteinSimple
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Domain Associates, L.L.C., please visit www.domainvc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.